Novo Nordisk AS (NVO)
85.00
-18.44
(-17.83%)
USD |
NYSE |
Dec 20, 16:00
86.00
+1.00
(+1.18%)
After-Hours: 20:00
Novo Nordisk Total Liabilities (Quarterly): 41.48B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ascendis Pharma AS | 1.330B |
| Evaxion Biotech AS | 15.18M |
| Amgen Inc | 83.36B |
| Viking Therapeutics Inc | 26.44M |
| Akari Therapeutics PLC | 9.428M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 59.53B |
| Shareholders Equity (Quarterly) | 18.05B |
| Debt to Equity Ratio | 0.4727 |
| Current Ratio | 0.9367 |
| Net Debt Paydown Yield | -0.18% |